Cargando…
Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
BACKGROUND: Breast cancer stem cells (BCSCs) are the source of breast tumors. Compared with other cancer cells, cancer stem cells show high resistance to both chemotherapy and radiotherapy. Targeting of BCSCs is thus a potentially promising and effective strategy for breast cancer treatment. Differe...
Autores principales: | Pham, Phuc V, Phan, Nhan LC, Nguyen, Nhung T, Truong, Nhung H, Duong, Thuy T, Le, Dong V, Truong, Kiet D, Phan, Ngoc K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251542/ https://www.ncbi.nlm.nih.gov/pubmed/22152097 http://dx.doi.org/10.1186/1479-5876-9-209 |
Ejemplares similares
-
Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011) -
Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment
por: Van Pham, Phuc, et al.
Publicado: (2012) -
Activated platelet-rich plasma improves adipose-derived stem cell transplantation efficiency in injured articular cartilage
por: Van Pham, Phuc, et al.
Publicado: (2013) -
Comparison of the Treatment Efficiency of Bone Marrow-Derived Mesenchymal Stem Cell Transplantation via Tail and Portal Veins in CCl(4)-Induced Mouse Liver Fibrosis
por: Truong, Nhung Hai, et al.
Publicado: (2016) -
A simple in vitro method for evaluating dendritic cell-based vaccinations
por: Pham, Phuc Van, et al.
Publicado: (2014)